United States · FDA National Drug Code directory
EDURANT PED
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59676-280_3d6d0fcc-0b62-b76b-e063-6294a90aea43
- Product NDC
- 59676-280
- Form
- TABLET, FOR SUSPENSION
- Composition / generic term
- rilpivirine hydrochloride
- Labeler
- Janssen Products, LP
- Marketing category
- NDA
- Marketing start / end (source format)
- 20240315
- Source listing expiry
- 20261231
Source-listed ingredients
- RILPIVIRINE HYDROCHLORIDE — 2.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 9 BLISTER PACK in 1 CARTON (59676-280-90) / 10 TABLET, FOR SUSPENSION in 1 BLISTER PACK (59676-280-01) · 59676-280-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →